跳至主要内容
临床试验/NCT03319186
NCT03319186Unknown不适用

Pre-EDIT: A Randomised, Feasibility Trial of Elastance-Directed Intra-pleural Catheter or Talc Pleurodesis (EDIT) in the Management of Symptomatic Malignant Pleural Effusion Without Obvious Non-expansile Lung

NHS Greater Glasgow and Clyde1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年8月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Feasibility of recruiting 30 patients within 12 months and randomising them to either EDIT Management or Standard Care

研究概览

简要总结

Malignant Pleural Effusion (MPE) is a collection of fluid inside the chest caused by cancer. It is a common medical problem and often causes severe breathlessness. Patients with this condition generally have a very poor survival and so it is extremely important that they are given effective treatment as soon as possible to minimise the amount of time they have to spend in hospital.

Standard treatment for MPE involves an admission to hospital to drain the fluid and then attempt to prevent the fluid from returning by sticking the lung to the inside of the rib cage with medical talc powder which acts like glue. This is called talc pleurodesis (TP) but unfortunately it fails in about 30% of patients. This is usually because the lung has not fully re-expanded and has not made contact with the inside of the ribs. When this happens, the fluid can be effectively treated with a different type of drainage tube called an indwelling pleural catheter (IPC) which tunnels under the skin and is drained at home by the district nurses.

It is thought that pressure measurements taken from the fluid as it is drained may be able to show doctors whether or not the lung will re-expand before patients are committed to either TP or an IPC. In this research we wish to test if these measurements can be used to choose which is the best first treatment option (TP or IPC) for patients with MPE. We have called this 'EDIT management'. Since it is uncertain whether this new approach will work, patients will be randomised to have either standard treatment or EDIT management. We will compare the two groups to assess whether the patients who had EDIT management had to have fewer repeat procedures over the following 3 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically confident diagnosis of malignant pleural effusion, defined as any of the following:
  • Pleural effusion with histocytologically proven pleural malignancy OR
  • Pleural effusion in the context of histocytologically proven malignancy elsewhere, without a clear alternative cause for fluid OR
  • Pleural effusion with typical features of malignancy with pleural involvement on cross-sectional imaging (CT/MRI)
  • Degree of breathlessness for which therapeutic pleural intervention would be offered
  • Age >18 years
  • Expected survival > 3 months
  • Written Informed Consent

排除标准

  • Females who are pregnant or lactating
  • Clinical suspicion of non-expansile lung for which talc pleurodesis would not be offered
  • Patient preference for 1st-line indwelling pleural catheter (IPC) insertion
  • Previous ipsilateral failed talc pleurodesis
  • Estimated pleural fluid volume ≤ 1 litre, as defined by thoracic ultrasound
  • Any contraindication to chest drain or IPC insertion, including:
  • Irreversible coagulopathy Inaccessible pleural collection, including lack of suitable IPC tunnel site
  • Any contraindication to MRI scanning, including:
  • Claustrophobia Cardiac pacemaker Ferrous metal implants or retained ferrous metal foreign body Previously documented reaction to Gadolinium-containing intravenous contrast agent Significant renal impairment (eGFR<30 ml/min)

研究组 & 干预措施

Standard Care

Active Comparator

干预措施: Chest drain and talc pleurodesis (Procedure)

EDIT Management

Experimental

干预措施: EDIT Management (Procedure)

结局指标

主要结局

Feasibility of recruiting 30 patients within 12 months and randomising them to either EDIT Management or Standard Care

时间窗: 12 months

The number of patients recruited and randomised within 12 months

次要结局

  • Incidence of adverse events associated with the manometry procedure(12 months)
  • Proportion of patients requiring pneumothorax induction following manometry(12 months)
  • Aspiration threshold to detect abnormal pleural elastance(12 months)
  • Assess accuracy of pleural cavity volume change assumptions(12 months)
  • Failure rate of the manometry procedure(12 months)
  • Assess accuracy of ultrasound effusion volume estimate(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验